T-Cell Activation Leucine Repeat Rich Protein (TALRRP)

[Edit]

TA-LRRP; LRRC8B; Leucine Rich Repeat Containing 8 Family Member B; Volume-regulated anion channel subunit LRRC8B

T-Cell Activation Leucine Repeat Rich Protein (TALRRP)
The deduced 803-amino acid protein contains 4 N-terminal transmembrane domains and 16 C-terminal leucine-rich repeats. LRRC8B shares 59% amino acid identity with LRRC8A and 93% identity with the mouse ortholog, which also contains 803 amino acids. Semiquantitative PCR detected variable LRRC8B expression in all tissues examined except skeletal muscle.The transcript contains an Alu element in its 3-prime end. The deduced protein contains several leucine-rich repeats and shares significant similarity with yeast adenylate cyclase. Northern blot analysis detected low LRRC8B expression in all tissues and cell lines examined.expression of LRRC8B in isolated human peripheral blood mononuclear cells or monocytes was increased following exposure to phytohemagglutinin, phorbol ester, or lipopolysaccharide.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for T-Cell Activation Leucine Repeat Rich Protein (TALRRP) CLIA Kit Customized Service Offer
n/a ELISA Kit for T-Cell Activation Leucine Repeat Rich Protein (TALRRP) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for T-Cell Activation Leucine Repeat Rich Protein (TALRRP) CLIA Kit Customized Service Offer
n/a ELISA Kit for T-Cell Activation Leucine Repeat Rich Protein (TALRRP) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to T-Cell Activation Leucine Repeat Rich Protein (TALRRP) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for T-Cell Activation Leucine Repeat Rich Protein (TALRRP) CLIA Kit Customized Service Offer
n/a ELISA Kit for T-Cell Activation Leucine Repeat Rich Protein (TALRRP) ELISA Kit Customized Service Offer
  1. "Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain."DNA Res. 3:321-329(1996) [PubMed] [Europe PMC] [Abstract]
  2. "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. "LRRC8 proteins share a common ancestor with pannexins, and may form hexameric channels involved in cell-cell communication."Bioessays 34:551-560(2012) [PubMed] [Europe PMC] [Abstract]
  5. "Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC."Science 344:634-638(2014) [PubMed] [Europe PMC] [Abstract]